Welcome to Critical Mass, Law.com’s weekly briefing on class actions and mass torts. I’m Max Mitchell in Philadelphia filling in for our usual columnist Amanda Bronstad.
Banking and tech companies topped the week’s litigation news, with websites behaving badly and attorneys netting $300 million in a blockbuster antitrust suit. A closely watched antitrust case against Allergan also settled, and plaintiffs firms are finding that experts who can speak on the subject of erectile dysfunction may be few and far-between.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
